Identification of alkaptonuria in the general population: A United Kingdom experience describing the challenges, possible solutions and persistent barriers

Journal of Inherited Metabolic Disease

Volumn 34, Issue 3, 2011, Pages 723-730

  Ranganath, L ^a   Taylor, A M ^b   Shenkin, A ^b   Fraser, W D ^b   Jarvis, J ^b   Gallagher, J A ^b   Sireau, N ^c  

^a ROYAL LIVERPOOL UNIVERSITY HOSPITAL   (United Kingdom)

^b UNIVERSITY OF LIVERPOOL   (United Kingdom)

^c Department of Clinical Biochemistry   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ALKAPTONURIA; ARTICLE; CHILD; FEMALE; GENERAL PRACTITIONER; GENETIC SCREENING; HUMAN; INFORMATION SERVICE; MAJOR CLINICAL STUDY; MALE; PATIENT IDENTIFICATION; QUESTIONNAIRE; SCHOOL CHILD; SOCIAL NETWORK; UNITED KINGDOM;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ALKAPTONURIA; CHILD; COMMUNICATION BARRIERS; FEMALE; GREAT BRITAIN; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; POPULATION; YOUNG ADULT;

EID: 79959776685     PISSN: 01418955     EISSN: 15732665     Source Type: Journal    
DOI: 10.1007/s10545-011-9282-z     Document Type: Article

References (23)

1. Abdulrazzaq YM, Bener A, Al-Gazali LI, Al-Khayat AI, Micallef R, Gaber T (1997) A study of possible deleterious effects of consanguineous marriages. Clin Genet 51:167-73 (Pubitemid 27168383)
2. Abdulrazzaq YM, Ibrahim A, Al-Khayat A, Nagelkerke N, Ali BR (2009) R58fs mutation in the HGD gene in a family with alkaptonuria in the UAE. Ann Hum Genet 73:125-30
3. Al-Gazali IL, Dawodu AH, Sabarinathan K, Varghese M (1995) The profile of major congenital abnormalities in the United Arab Emirates (UAE) population. J Med Genet 32:7-13
4. Bedgood R, Sadurski R, Schade RR (2007) The use of the internet in data assimilation in rare diseases. Dig Dis Sci 52:307-12 (Pubitemid 46202797)
5. Bremond-Gignac D, Donadieu J, Leonardi A et al (2008) Prevalence of vernal keratoconjunctivitis: a rare disease? Br J Ophthalmol 92:1097-102
6. Bygum A (2009) Hereditary angio-oedema in Denmark: a nationwide survey. Br J Dermatol 161:1153-8
7. Elliott EJ, Chant KG (1994) Rare disease surveillance. J Paediatr Child Health 30:463-5 (Pubitemid 24355421)
8. Guillem P, Cans C, Robert-Gnansia E, Ayme S, Jouk PS (2008) Rare diseases in disabled children: an epidemiological survey. Arch Dis Child 93:115-8 (Pubitemid 351204750)
9. Helliwell TR, Gallagher JA, Ranganath L (2008) Alkaptonuria - a review of surgical and autopsy pathology. Histopathology 53:503-12
10. International Human Genome Sequencing Consortium (2004) Finishing the euchromatic sequence of the human genome.Nature 431:931-45
11. Knight M, Kurinczuk JJ, Tuffnell D, Brocklehurst P (2005) The UK obstetric surveillance system for rare disorders of pregnancy. BJOG Int J Obstetr Gynaecol 112:263-5 (Pubitemid 40313997)
12. Laverty A, Jaffe A, Cunningham S (2008) Establishment of a web-based registry for rare (orphan) pediatric lung diseases in the United Kingdom: the BPOLD registry. Pediatric Pulmonol 43:451-6 (Pubitemid 351657311)
13. Nichol A, Lynn R, Rahi J, Verity C, Haines L (2000) Public health outputs from the British Paediatric Surveillance Unit and similar clinician-based systems. J R Soc Med 93:580-5
14. Oluwatowoju I, Abu E, Wild SH, Byrne CD (2010) Improvements in glycaemic control and cholesterol concentrations associated with the quality and outcomes framework: a regional 2-year audit of diabetes care in the UK. Diabet Med 27:354-9
15. Phornphutkul C, Introne WJ, Perry MB et al (2002) Natural history of alkaptonuria. N Engl J Med 347:2111-21 (Pubitemid 36015123)
16. Schwarzer U, Sommer F, Klotz T, Braun M, Reifenrath B, Engelmann U (2001) The prevalence of Peyronie's disease: results of a large survey. BJU Int 88:727-30
17. Siriwardena AN (2010) Should the quality and outcomes framework be abolished? No. Br Med J 340:2794-9
18. Srsen S, Muller CR, Fregin A, Srsnova K (2002) Alkaptonuria in Slovakia: thirty-two years of research on phenotype and genotype. Mol Genet Metab 75:353-9 (Pubitemid 34971585)
19. Suwannarat P, O'Brien K, Perry MB et al (2005) Use of nitisinone in patients with alkaptonuria. Metab Clin Exp 54:719-28 (Pubitemid 40725319)
20. Thacker SB, Berkelman RL (1988) Public health surveillance in the United States. Epidemiol Rev 10:164-90 (Pubitemid 18262844)
21. Vilboux T, Kayser M, Introne W, Suwannarat P, Bernardini I, O'Brien K et al (2009) Mutation spectrum of homogentisic acid oxidase (HGD) in alkaptonuria. Hum Mutat 30:1611-9
22. Vogt RL, La Rue D, Klaucke D, Jillson DA (1983) Comparison of active and passive surveillance systems of primary care providers for hepatitis, measles, rubella and salmonellosis in Vermont. Am J Public Health 73:795-7 (Pubitemid 13059142)
23. Zatkova A, de Bernabe DBV, Polakova H et al (2000) High frequency of alkaptonuria in Slovakia: evidence for the appearance of multiple mutations in HGO involving different mutational hot spots. Am J Hum Genet 67:1333-9